Arbovirus Testing Market Analysis

Arbovirus Testing Test Market Analysis

The arbovirus testing market by test type is segmented into RT-PCR based tests, ELISA-based tests, and others. The ELISA-based tests held the largest revenue size accounting for more than USD 530 million in 2022 and is estimated to witness significant growth over the forecasted timeline. The high revenue share is primarily attributable to the high focus on research and development activities and technological advancements in ELISA testing for detection of arbovirus disorders. Several innovations and continuous improvements in assay design, sensitivity, and specificity including development of multiplex ELISA assays for enhanced diagnostic efficiency and cost-effectiveness will offer substantial segmental growth potential.
 

Also, ELISA-based tests utilize in assessing the efficacy of vector control measures, identifying high-risk areas, and guiding targeted interventions that will bolster segment demand. Further, High investments in arbovirus surveillance programs and the availability of accurate and accessible ELISA-based tests are anticipated to propel segment revenue size.
 

The arbovirus testing market by end-use is categorized into hospitals, diagnostic centers, public health laboratory and others. Public health laboratory segment garnered highest revenue share in the year 2022 and is estimated to witness significant growth at 5.6% CAGR over the estimated timeframe. Expanding number of public health laboratories among several economies will boost the public health laboratory segment growth. Adoption of advanced diagnostic technologies for arbovirus testing such as rapid molecular assays, next-generation sequencing and high-throughput platforms that enable faster and more accurate detection of arboviruses in the facilities is anticipated to boost customer preference towards public health laboratory segment.
 

Further, Public health laboratories are actively collaborating with research institutions, diagnostic companies, and public health agencies to enhance their capabilities in arbovirus testing to promote knowledge sharing, standardization of testing protocols, and the development of new technologies leading to improved testing accuracy, efficiency, and harmonization across different laboratory settings. Such technological advancements will drive the public health laboratories growth potential.
 

U.S. arbovirus testing market accounted for over USD 400 million in 2022 and is estimated to witness substantial market growth over the forecast period.  The surge in incidence and prevalence of arbovirus diseases and booming geriatric population that are highly prone to viral diseases in the country are few factors accelerating market growth.
 

Furthermore, surge in point of care molecular diagnostics among clinical facilities, well-established healthcare infrastructure, growing R&D expenditures, high usage of sophisticated diagnostic tests and increase in healthcare spending will positively influence the market in the U.S. Also, establishment of comprehensive surveillance programs, strengthening of laboratory networks and the development of integrated response strategies to minimize arbovirus diseases will boost market demand in the U.S.